Table of Contents

Executive Summary

1 Industry Overview of Pompe Disease Treatment

• 1.1 Definition of Pompe Disease Treatment
• 1.2 Pompe Disease Treatment Segment by Type
  • 1.2.1 Global Pompe Disease Treatment Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Infantile-Onset Pompe Disease
  • 1.2.3 Adult-Onset Pompe Disease
• 1.3 Pompe Disease Treatment Segment by Applications
  • 1.3.1 Global Pompe Disease Treatment Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Medical Center
  • 1.3.4 Other
• 1.4 Global Pompe Disease Treatment Overall Market
  • 1.4.1 Global Pompe Disease Treatment Revenue (2014-2025)
  • 1.4.2 Global Pompe Disease Treatment Production (2014-2025)
  • 1.4.3 North America Pompe Disease Treatment Status and Prospect (2014-2025)
  • 1.4.4 Europe Pompe Disease Treatment Status and Prospect (2014-2025)
  • 1.4.5 China Pompe Disease Treatment Status and Prospect (2014-2025)
  • 1.4.6 Japan Pompe Disease Treatment Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Pompe Disease Treatment Status and Prospect (2014-2025)
  • 1.4.8 India Pompe Disease Treatment Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Pompe Disease Treatment
• 2.3 Manufacturing Process Analysis of Pompe Disease Treatment
• 2.4 Industry Chain Structure of Pompe Disease Treatment

3 Development and Manufacturing Plants Analysis of Pompe Disease Treatment

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Pompe Disease Treatment Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Pompe Disease Treatment
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Pompe Disease Treatment Production and Capacity Analysis
• 4.2 Pompe Disease Treatment Revenue Analysis
• 4.3 Pompe Disease Treatment Price Analysis
• 4.4 Market Concentration Degree

5 Pompe Disease Treatment Regional Market Analysis

• 5.1 Pompe Disease Treatment Production by Regions
  • 5.1.1 Global Pompe Disease Treatment Production by Regions
  • 5.1.2 Global Pompe Disease Treatment Revenue by Regions
• 5.2 Pompe Disease Treatment Consumption by Regions
• 5.3 North America Pompe Disease Treatment Market Analysis
  • 5.3.1 North America Pompe Disease Treatment Production
  • 5.3.2 North America Pompe Disease Treatment Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Pompe Disease Treatment Import and Export
• 5.4 Europe Pompe Disease Treatment Market Analysis
  • 5.4.1 Europe Pompe Disease Treatment Production
  • 5.4.2 Europe Pompe Disease Treatment Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Pompe Disease Treatment Import and Export
• 5.5 China Pompe Disease Treatment Market Analysis
  • 5.5.1 China Pompe Disease Treatment Production
  • 5.5.2 China Pompe Disease Treatment Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Pompe Disease Treatment Import and Export
• 5.6 Japan Pompe Disease Treatment Market Analysis
  • 5.6.1 Japan Pompe Disease Treatment Production
  • 5.6.2 Japan Pompe Disease Treatment Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Pompe Disease Treatment Import and Export
• 5.7 Southeast Asia Pompe Disease Treatment Market Analysis
  • 5.7.1 Southeast Asia Pompe Disease Treatment Production
  • 5.7.2 Southeast Asia Pompe Disease Treatment Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Pompe Disease Treatment Import and Export
• 5.8 India Pompe Disease Treatment Market Analysis
  • 5.8.1 India Pompe Disease Treatment Production
  • 5.8.2 India Pompe Disease Treatment Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Pompe Disease Treatment Import and Export

6 Pompe Disease Treatment Segment Market Analysis (by Type)

• 6.1 Global Pompe Disease Treatment Production by Type
• 6.2 Global Pompe Disease Treatment Revenue by Type
• 6.3 Pompe Disease Treatment Price by Type

7 Pompe Disease Treatment Segment Market Analysis (by Application)

• 7.1 Global Pompe Disease Treatment Consumption by Application
• 7.2 Global Pompe Disease Treatment Consumption Market Share by Application (2014-2019)

8 Pompe Disease Treatment Major Manufacturers Analysis

• 8.1 Amicus Therapeutics
  • 8.1.1 Amicus Therapeutics Pompe Disease Treatment Production Sites and Area Served
  • 8.1.2 Amicus Therapeutics Product Introduction, Application and Specification
  • 8.1.3 Amicus Therapeutics Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Audentes Therapeutics
  • 8.2.1 Audentes Therapeutics Pompe Disease Treatment Production Sites and Area Served
  • 8.2.2 Audentes Therapeutics Product Introduction, Application and Specification
  • 8.2.3 Audentes Therapeutics Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Sanofi Genzyme
  • 8.3.1 Sanofi Genzyme Pompe Disease Treatment Production Sites and Area Served
  • 8.3.2 Sanofi Genzyme Product Introduction, Application and Specification
  • 8.3.3 Sanofi Genzyme Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 EpiVax
  • 8.4.1 EpiVax Pompe Disease Treatment Production Sites and Area Served
  • 8.4.2 EpiVax Product Introduction, Application and Specification
  • 8.4.3 EpiVax Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Oxyrane
  • 8.5.1 Oxyrane Pompe Disease Treatment Production Sites and Area Served
  • 8.5.2 Oxyrane Product Introduction, Application and Specification
  • 8.5.3 Oxyrane Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Sangamo BioSciences
  • 8.6.1 Sangamo BioSciences Pompe Disease Treatment Production Sites and Area Served
  • 8.6.2 Sangamo BioSciences Product Introduction, Application and Specification
  • 8.6.3 Sangamo BioSciences Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Valerion Therapeutics
  • 8.7.1 Valerion Therapeutics Pompe Disease Treatment Production Sites and Area Served
  • 8.7.2 Valerion Therapeutics Product Introduction, Application and Specification
  • 8.7.3 Valerion Therapeutics Pompe Disease Treatment Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served

9 Development Trend of Analysis of Pompe Disease Treatment Market

• 9.1 Global Pompe Disease Treatment Market Trend Analysis
  • 9.1.1 Global Pompe Disease Treatment Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Pompe Disease Treatment Regional Market Trend
  • 9.2.1 North America Pompe Disease Treatment Forecast 2019-2025
  • 9.2.2 Europe Pompe Disease Treatment Forecast 2019-2025
  • 9.2.3 China Pompe Disease Treatment Forecast 2019-2025
  • 9.2.4 Japan Pompe Disease Treatment Forecast 2019-2025
  • 9.2.5 Southeast Asia Pompe Disease Treatment Forecast 2019-2025
  • 9.2.6 India Pompe Disease Treatment Forecast 2019-2025
• 9.3 Pompe Disease Treatment Market Trend (Product Type)
• 9.4 Pompe Disease Treatment Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Pompe Disease Treatment Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List

Pompe disease is a rare disease, also known as acid maltase deficiency (AMD) or glycogen storage disorder (GSD).Glycogenosis II is also called "glycogenosis type 2".
The availability of reimbursement policies for the treatment Pompe disease as one of the primary factors that will have a positive impact on the growth of this market.

The global Pompe Disease Treatment market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Pompe Disease Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pompe Disease Treatment market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Pompe Disease Treatment in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Pompe Disease Treatment manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amicus Therapeutics
Audentes Therapeutics
Sanofi Genzyme
EpiVax
Oxyrane
Sangamo BioSciences
Valerion Therapeutics
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Infantile-Onset Pompe Disease
Adult-Onset Pompe Disease

Segment by Application
Hospital
Medical Center
Other